JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2626
PetMed Express
PETS
$29.3M
| $4.63M | ﹤0.01% |
101,719
+65,220
| +179% | +$2.57M |
2015 Q4
8 quarters
|
|
|
DEL
2627
DELISTED
Deltic Timber
DEL
| $4.62M | ﹤0.01% |
50,461
+50,038
| +11,829% | +$4.58M |
2016 Q4
4 quarters
|
|
|
WNS
2628
DELISTED
WNS Holdings
WNS
| $4.61M | ﹤0.01% |
114,746
+98,518
| +607% | +$3.87M |
2016 Q3
5 quarters
|
|
|
SGEN
2629
PUT
DELISTED
Seagen Inc. Common Stock
SGEN
| $4.6M | ﹤0.01% |
86,000
+36,000
| +72% | +$2.1M |
2017 Q3
1 quarter
|
|
2630
AngloGold Ashanti
AU
$48.1B
| $4.6M | ﹤0.01% |
451,282
+417,146
| +1,222% | +$4.02M |
2014 Q2
14 quarters
|
|
2631
TG Therapeutics
TGTX
$8.32B
| $4.59M | ﹤0.01% |
559,553
+201,928
| +56% | +$1.76M |
2016 Q4
4 quarters
|
|
|
LCI
2632
DELISTED
Lannett Company, Inc.
LCI
| $4.58M | ﹤0.01% |
49,387
-27,140
| -35% | -$2.65M |
2015 Q4
8 quarters
|
|
2633
Tompkins Financial
TMP
$1.42B
| $4.58M | ﹤0.01% |
56,315
+8,012
| +17% | +$680K |
2013 Q2
18 quarters
|
|
2634
PUT
WIX.com
WIX
$3.03B
| $4.58M | ﹤0.01% |
+79,600
| New | +$4.93M |
2017 Q4
0 quarters
|
|
2635
Pegasystems
PEGA
$5.59B
| $4.56M | ﹤0.01% |
193,344
+112,214
| +138% | +$3.01M |
2013 Q2
18 quarters
|
|
|
TOWR
2636
DELISTED
Tower International, Inc.
TOWR
| $4.56M | ﹤0.01% |
149,237
+25,792
| +21% | +$780K |
2013 Q3
17 quarters
|
|
2637
Hurco Companies Inc
HURC
$146M
| $4.56M | ﹤0.01% |
108,009
+2,693
| +3% | +$117K |
2013 Q2
18 quarters
|
|
2638
PUT
Equifax
EFX
$16.5B
| $4.55M | ﹤0.01% |
38,600
| – | – |
2017 Q3
1 quarter
|
|
|
IPCC
2639
DELISTED
Infinity Property & Casualty C
IPCC
| $4.54M | ﹤0.01% |
42,858
+26,694
| +165% | +$2.71M |
2015 Q4
8 quarters
|
|
2640
Provident Financial Services
PFS
$2.94B
| $4.54M | ﹤0.01% |
168,300
+67,736
| +67% | +$1.84M |
2013 Q2
18 quarters
|
|
2641
PUT
General Dynamics
GD
$89.4B
| $4.54M | ﹤0.01% |
22,300
+6,000
| +37% | +$1.23M |
2017 Q3
1 quarter
|
|
|
AJRD
2642
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $4.53M | ﹤0.01% |
145,328
+42,782
| +42% | +$1.36M |
2015 Q4
8 quarters
|
|
2643
International Bancshares
IBOC
$4.34B
| $4.53M | ﹤0.01% |
114,069
+78,476
| +220% | +$3.17M |
2015 Q4
8 quarters
|
|
2644
Coherent
COHR
$65.8B
| $4.53M | ﹤0.01% |
96,356
+95,327
| +9,264% | +$4.28M |
2013 Q2
18 quarters
|
|
|
PDCO
2645
PUT
DELISTED
Patterson Companies, Inc.
PDCO
| $4.52M | ﹤0.01% |
125,000
| – | – |
2017 Q3
1 quarter
|
|
|
GOLD
2646
DELISTED
Randgold Resources Ltd
GOLD
| $4.51M | ﹤0.01% |
45,563
-54,544
| -54% | -$5.18M |
2013 Q2
18 quarters
|
|
2647
CALL
BioMarin Pharmaceuticals
BMRN
$11.2B
| $4.46M | ﹤0.01% |
+50,000
| New | +$4.35M |
2017 Q4
0 quarters
|
|
|
2648
PUT
BioMarin Pharmaceuticals
BMRN
$11.2B
| $4.46M | ﹤0.01% |
+50,000
| New | +$4.35M |
2017 Q4
0 quarters
|
|
2649
CALL
Dominion Energy
D
$54B
| $4.46M | ﹤0.01% |
+55,000
| New | +$4.46M |
2017 Q4
0 quarters
|
|
|
2650
PUT
Dominion Energy
D
$54B
| $4.46M | ﹤0.01% |
+55,000
| New | +$4.46M |
2017 Q4
0 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.